Abstract
Thiourea derivatives have drawn much attention for their latent capacities of biological activities. In this study, we designed acylthiourea compounds as polo-like kinase 1 (Plk1) polo-box domain (PBD) inhibitors. A series of acylthiourea derivatives without pan assay interference structure (PAINS) were synthesized. Four compounds with halogen substituents exhibited binding affinities to Plk1 PBD in low micromole range. The most potent compound (3v) showed selectivity over other subtypes of Plk PBDs and inhibited the kinase activity of full-length Plk1.
Keywords:
Binding affinity; Halogenosulfamoylphenyl acylthiourea; In vitro assay; Polo-box domain; Polo-like kinase 1; Small molecular inhibitor.
Copyright © 2016 Elsevier Masson SAS. All rights reserved.
MeSH terms
-
Cell Cycle Proteins / antagonists & inhibitors*
-
Cell Cycle Proteins / chemistry*
-
Cell Cycle Proteins / metabolism
-
Cell Proliferation / drug effects
-
Drug Evaluation, Preclinical
-
Halogens / chemistry
-
HeLa Cells
-
Humans
-
Molecular Docking Simulation
-
Polo-Like Kinase 1
-
Protein Domains
-
Protein Kinase Inhibitors / chemistry*
-
Protein Kinase Inhibitors / metabolism
-
Protein Kinase Inhibitors / pharmacology*
-
Protein Serine-Threonine Kinases / antagonists & inhibitors*
-
Protein Serine-Threonine Kinases / chemistry*
-
Protein Serine-Threonine Kinases / metabolism
-
Proto-Oncogene Proteins / antagonists & inhibitors*
-
Proto-Oncogene Proteins / chemistry*
-
Proto-Oncogene Proteins / metabolism
-
Substrate Specificity
-
Thiourea / chemistry*
-
Thiourea / metabolism
-
Thiourea / pharmacology*
Substances
-
Cell Cycle Proteins
-
Halogens
-
Protein Kinase Inhibitors
-
Proto-Oncogene Proteins
-
Protein Serine-Threonine Kinases
-
Thiourea